NO20006161L - Topisk tilförsel av oksazolidinoner for transdermal levering - Google Patents

Topisk tilförsel av oksazolidinoner for transdermal levering

Info

Publication number
NO20006161L
NO20006161L NO20006161A NO20006161A NO20006161L NO 20006161 L NO20006161 L NO 20006161L NO 20006161 A NO20006161 A NO 20006161A NO 20006161 A NO20006161 A NO 20006161A NO 20006161 L NO20006161 L NO 20006161L
Authority
NO
Norway
Prior art keywords
topical administration
oxazolidinones
transdermal delivery
infections
bacteremia
Prior art date
Application number
NO20006161A
Other languages
English (en)
Other versions
NO20006161D0 (no
Inventor
Charles W Ford
Jeffrey L Watts
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20006161L publication Critical patent/NO20006161L/no
Publication of NO20006161D0 publication Critical patent/NO20006161D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det beskrives en fremgangsmåte for behandling av en ikke-topisk infeksjon utvalgt fra gruppen sombestår av øreinfeksjoner, infeksjoner i hud og mykt vev, akne, infiserte sår og bakteriemi, i et anvendbart, varmblodig pattedyr med behov for slik behandling, som omfatter topisk tilførsel av et farmasøytisk preparat inneholdende en transdermalt effektiv mengde av et oksazolidinon.
NO20006161A 1998-06-05 2000-12-04 Topisk tilförsel av oksazolidinoner for transdermal levering NO20006161D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8828398P 1998-06-05 1998-06-05
PCT/US1999/010463 WO1999062504A2 (en) 1998-06-05 1999-05-26 Topical administration of oxazolidinones for transdermal delivery

Publications (2)

Publication Number Publication Date
NO20006161L true NO20006161L (no) 2000-12-04
NO20006161D0 NO20006161D0 (no) 2000-12-04

Family

ID=22210475

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006161A NO20006161D0 (no) 1998-06-05 2000-12-04 Topisk tilförsel av oksazolidinoner for transdermal levering

Country Status (29)

Country Link
US (2) US6613349B2 (no)
EP (1) EP1083900B1 (no)
JP (1) JP2002516852A (no)
KR (1) KR100626781B1 (no)
CN (1) CN1168447C (no)
AT (1) ATE220548T1 (no)
AU (1) AU749523B2 (no)
BR (1) BR9910318A (no)
CA (1) CA2327326A1 (no)
CO (1) CO5011042A1 (no)
CZ (1) CZ292420B6 (no)
DE (1) DE69902170T2 (no)
DK (1) DK1083900T3 (no)
EA (1) EA003699B1 (no)
ES (1) ES2179658T3 (no)
HK (1) HK1036593A1 (no)
HU (1) HU225234B1 (no)
ID (1) ID23775A (no)
IL (1) IL139843A0 (no)
MY (1) MY122454A (no)
NO (1) NO20006161D0 (no)
NZ (1) NZ508636A (no)
PL (1) PL193535B1 (no)
PT (1) PT1083900E (no)
SK (1) SK285352B6 (no)
TR (1) TR200003205T2 (no)
TW (1) TWI224000B (no)
WO (1) WO1999062504A2 (no)
ZA (1) ZA200005886B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562820B2 (en) * 2000-07-05 2003-05-13 Pharmacia & Upjohn Company Method for treatment and prevention of mastitis
US20030096850A1 (en) * 2001-10-11 2003-05-22 Ford Charles W. Treating infections by administration of oxazolidinones
BR0308806A (pt) * 2002-03-29 2005-01-04 Upjohn Co Uso de oxazolidinonas para tratar infecções do tipo pé diabético
US20060222692A1 (en) * 2005-03-31 2006-10-05 Fairfield Clinical Trials Llc Method and compositions for transdermal administration of antimicrobial medications
CN112409285A (zh) * 2020-11-30 2021-02-26 山东金城昆仑药业有限公司 噁唑烷酮类化合物的晶型及其制备方法和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3743727A (en) 1970-11-16 1973-07-03 Crown Zellerbach Corp Enhancing tissue penetration of certain antimicrobial agents with dimethyl sulfoxide
US4507287A (en) 1983-06-20 1985-03-26 Dixon Glen J Preparation and method for the treatment of acne
JP2558107B2 (ja) 1986-12-18 1996-11-27 第一製薬株式会社 外用剤
US4943435A (en) 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
US4960771A (en) 1988-07-12 1990-10-02 Rajadhyaksha Vithal J Oxazolidinone penetration enhancing compounds
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5164510A (en) 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
US5231188A (en) 1989-11-17 1993-07-27 The Upjohn Company Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
EP0610265B1 (en) 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US5457194A (en) * 1993-03-17 1995-10-10 Abbott Laboratories Substituted aliphatic amine-containing macrocyclic immunomodulators
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
JP3698724B2 (ja) 1993-11-22 2005-09-21 ファルマシア・アンド・アップジョン・カンパニー 置換−ヒドロキシアセチルピペラジンフェニルオキサゾリジノンのエステル
DE4425612A1 (de) 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
DE4425613A1 (de) 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
JP4102901B2 (ja) 1994-09-14 2008-06-18 スリーエム カンパニー 経皮薬剤導入用マトリックス
US5604262A (en) * 1995-03-22 1997-02-18 Research Corporation Technologies, Inc. Topical antimicrobial agents
ZA968661B (en) * 1995-11-17 1998-04-14 Upjohn Co Oxazolidinone antibacterial agent with tricyclic substituents.
US5929086A (en) * 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
ATE229805T1 (de) * 1996-05-10 2003-01-15 Upjohn Co Topische verabreichung von premafloxacin zur behandlung von systemischen bakteriellen erkrankungen
US6040306A (en) * 1997-11-18 2000-03-21 Pharmacia & Upjohn Company Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
US6312715B1 (en) 1998-05-01 2001-11-06 3M Innovative Properties Company Adhesive microsphere drug delivery composition
US6174878B1 (en) * 1999-08-31 2001-01-16 Alcon Laboratories, Inc. Topical use of kappa opioid agonists to treat otic pain

Also Published As

Publication number Publication date
DK1083900T3 (da) 2002-11-04
SK285352B6 (sk) 2006-11-03
ID23775A (id) 2000-05-11
US20020009483A1 (en) 2002-01-24
CZ20004432A3 (cs) 2001-03-14
ZA200005886B (en) 2002-04-22
CA2327326A1 (en) 1999-12-09
US6613349B2 (en) 2003-09-02
ES2179658T3 (es) 2003-01-16
TR200003205T2 (tr) 2001-05-21
KR20010052555A (ko) 2001-06-25
EP1083900A2 (en) 2001-03-21
ATE220548T1 (de) 2002-08-15
TWI224000B (en) 2004-11-21
PL193535B1 (pl) 2007-02-28
US7892574B2 (en) 2011-02-22
DE69902170T2 (de) 2003-03-13
AU4184899A (en) 1999-12-20
HUP0102191A3 (en) 2003-07-28
CN1298302A (zh) 2001-06-06
US20040072841A1 (en) 2004-04-15
HK1036593A1 (en) 2002-01-11
NZ508636A (en) 2002-03-01
EA003699B1 (ru) 2003-08-28
SK16262000A3 (sk) 2001-06-11
JP2002516852A (ja) 2002-06-11
PL345119A1 (en) 2001-12-03
MY122454A (en) 2006-04-29
HU225234B1 (en) 2006-08-28
CN1168447C (zh) 2004-09-29
CO5011042A1 (es) 2001-02-28
EP1083900B1 (en) 2002-07-17
HUP0102191A2 (hu) 2002-05-29
IL139843A0 (en) 2002-02-10
PT1083900E (pt) 2002-12-31
NO20006161D0 (no) 2000-12-04
DE69902170D1 (de) 2002-08-22
WO1999062504A2 (en) 1999-12-09
BR9910318A (pt) 2001-01-30
KR100626781B1 (ko) 2006-09-22
AU749523B2 (en) 2002-06-27
CZ292420B6 (cs) 2003-09-17
EA200100010A1 (ru) 2001-06-25
WO1999062504A3 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
Reyzelman et al. Are antibiotics necessary in the treatment of locally infected ingrown toenails?
HUP9901991A2 (hu) Transzdermális eszköz flurbiprofén átadására
KR910700048A (ko) 오메프라졸의 항균제로서의 용도
US20110044917A1 (en) Dental composition for treating peri-implantitis
BR0307898A (pt) Formulações de droga antibiótica oftálmica contendo um composto de ciclodextrina e cloreto de cetil piridìnio
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
DK1153610T3 (da) Matrixproteinpræparater til inflammatoriske og infektiøse tilstande
AU3902299A (en) Methods of treating microbial infection and therapeutic formulations therefor
NO20006161L (no) Topisk tilförsel av oksazolidinoner for transdermal levering
NO20044672L (no) Parenteral, intravenos og oral administrering av oksazolidinoner for behandling av diabetiske fotinfeksjoner
DE69927380D1 (de) Oxazolidinones zur behandlung von augeninfektionen
Karlatti et al. A comparative prospective study of preoperative antibiotic prophylaxis in the prevention of surgical site infections
DE60030300D1 (de) Topische behandlung zur vorbeugung von augeninfektionen
UY26514A1 (es) " composición para el tratamiento de tejidos danados".
BR0014751A (pt) Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto
ECSP992967A (es) Aplicación topica de oxazolidinonas para administracion transdermica
Gustafson et al. Effect of local application of trypsin on postextraction alveolar osteitis
EP1053747A3 (de) Mittel zur Behandlung lokaler parodontaler Infektionen
SE9903499D0 (sv) Antimicrobial agent for treatment and prophylaxis
NO996117L (no) Anordning for tilfoering av medikamenter samt behandling av virale og mikrobielle infeksjoner og taeringssyndrom
NO20030483D0 (no) Assosiasjoner av dalfopristin/quinupristin med cefpirom
NO974941L (no) Ny anvendelse av (S)-adenosyl-L-metionin(SAMe)
UA33839A (uk) Спосіб хірургічного лікування проникаючих поранень рогівки ока
UA41815A (uk) Спосіб лікування пародонтиту

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application